科源制药(301281.SZ)拟推2025年限制性股票激励计划

Group 1 - The core point of the article is that Koyuan Pharmaceutical (301281.SZ) has announced a draft for a restricted stock incentive plan for 2025, proposing to grant a total of 3 million restricted shares, which accounts for approximately 2.77% of the company's total share capital at the time of the announcement [1] - The plan includes an initial grant of 2.4 million restricted shares, with an additional 600,000 shares reserved [1] - The grant price for the restricted shares is set at 14.71 yuan per share [1] Group 2 - The effective period of the incentive plan will last from the date of the first grant of restricted shares until all granted shares are vested or become invalid, with a maximum duration of 48 months [1]